カテゴリ： 世界, 医療/バイオ, Market Monitor Global

樹状細胞ワクチンのグローバル市場展望 2023年-2029年：非標的型、標的型

■ 英語タイトル：Dendritic Cell Vaccine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8450）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8450
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：115
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[樹状細胞ワクチンのグローバル市場展望 2023年-2029年：非標的型、標的型]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の樹状細胞ワクチン市場規模と予測を収録しています。・世界の樹状細胞ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の樹状細胞ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の樹状細胞ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非標的型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

樹状細胞ワクチンのグローバル主要企業は、3M、 Activarti、 Argos Therapeutics、 Batavia Bioservices、 Bellicum Pharmaceuticals、 Creagene、 DanDrit Biotech、 DCPrime、 Sanpower Corporation (Dendreon Corporation)、 Elios Therapeutics、 ImmunoCellular Therapeutics、 Immunicum、 Kiromic、 Medigene、 Merck & Co.、 Northwest Biotherapeutics、 Glaxo Smith Kline、 Tella Incorporation、 Vaxil BioTherapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、樹状細胞ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の樹状細胞ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の樹状細胞ワクチン市場：タイプ別市場シェア、2022年
・非標的型、標的型

世界の樹状細胞ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の樹状細胞ワクチン市場：用途別市場シェア、2022年
・新型コロナウイルス感染症、がん、その他

世界の樹状細胞ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の樹状細胞ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における樹状細胞ワクチンのグローバル売上、2018年-2023年
・主要企業における樹状細胞ワクチンのグローバル売上シェア、2022年
・主要企業における樹状細胞ワクチンのグローバル販売量、2018年-2023年
・主要企業における樹状細胞ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
3M、 Activarti、 Argos Therapeutics、 Batavia Bioservices、 Bellicum Pharmaceuticals、 Creagene、 DanDrit Biotech、 DCPrime、 Sanpower Corporation (Dendreon Corporation)、 Elios Therapeutics、 ImmunoCellular Therapeutics、 Immunicum、 Kiromic、 Medigene、 Merck & Co.、 Northwest Biotherapeutics、 Glaxo Smith Kline、 Tella Incorporation、 Vaxil BioTherapeutics

*************************************************************

・調査・分析レポートの概要
樹状細胞ワクチン市場の定義
市場セグメント
世界の樹状細胞ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の樹状細胞ワクチン市場規模
世界の樹状細胞ワクチン市場規模：2022年 VS 2029年
世界の樹状細胞ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの樹状細胞ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の樹状細胞ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非標的型、標的型
樹状細胞ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：新型コロナウイルス感染症、がん、その他
樹状細胞ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別樹状細胞ワクチン市場規模 2022年と2029年
地域別樹状細胞ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
3M、 Activarti、 Argos Therapeutics、 Batavia Bioservices、 Bellicum Pharmaceuticals、 Creagene、 DanDrit Biotech、 DCPrime、 Sanpower Corporation (Dendreon Corporation)、 Elios Therapeutics、 ImmunoCellular Therapeutics、 Immunicum、 Kiromic、 Medigene、 Merck & Co.、 Northwest Biotherapeutics、 Glaxo Smith Kline、 Tella Incorporation、 Vaxil BioTherapeutics
...

Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option.
This report aims to provide a comprehensive presentation of the global market for Dendritic Cell Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dendritic Cell Vaccine. This report contains market size and forecasts of Dendritic Cell Vaccine in global, including the following market information:
Global Dendritic Cell Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dendritic Cell Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dendritic Cell Vaccine companies in 2022 (%)
The global Dendritic Cell Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Non-Targeted Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dendritic Cell Vaccine include 3M, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime and Sanpower Corporation (Dendreon Corporation), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dendritic Cell Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, by Type, 2022 (%)
Non-Targeted
Target
Global Dendritic Cell Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, by Application, 2022 (%)
Covid-19
Cancer
Others
Global Dendritic Cell Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dendritic Cell Vaccine revenues share in global market, 2022 (%)
Key companies Dendritic Cell Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dendritic Cell Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon Corporation)
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck & Co.
Northwest Biotherapeutics
Glaxo Smith Kline
Tella Incorporation
Vaxil BioTherapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dendritic Cell Vaccine, market overview.
Chapter 2: Global Dendritic Cell Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Dendritic Cell Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dendritic Cell Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dendritic Cell Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Dendritic Cell Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dendritic Cell Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dendritic Cell Vaccine Overall Market Size
2.1 Global Dendritic Cell Vaccine Market Size: 2022 VS 2029
2.2 Global Dendritic Cell Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dendritic Cell Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Dendritic Cell Vaccine Players in Global Market
3.2 Top Global Dendritic Cell Vaccine Companies Ranked by Revenue
3.3 Global Dendritic Cell Vaccine Revenue by Companies
3.4 Global Dendritic Cell Vaccine Sales by Companies
3.5 Global Dendritic Cell Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dendritic Cell Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dendritic Cell Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dendritic Cell Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Dendritic Cell Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Dendritic Cell Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dendritic Cell Vaccine Market Size Markets, 2022 & 2029
4.1.2 Non-Targeted
4.1.3 Target
4.2 By Type – Global Dendritic Cell Vaccine Revenue & Forecasts
4.2.1 By Type – Global Dendritic Cell Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Dendritic Cell Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Dendritic Cell Vaccine Sales & Forecasts
4.3.1 By Type – Global Dendritic Cell Vaccine Sales, 2018-2023
4.3.2 By Type – Global Dendritic Cell Vaccine Sales, 2024-2029
4.3.3 By Type – Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Dendritic Cell Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dendritic Cell Vaccine Market Size, 2022 & 2029
5.1.2 Covid-19
5.1.3 Cancer
5.1.4 Others
5.2 By Application – Global Dendritic Cell Vaccine Revenue & Forecasts
5.2.1 By Application – Global Dendritic Cell Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Dendritic Cell Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Dendritic Cell Vaccine Sales & Forecasts
5.3.1 By Application – Global Dendritic Cell Vaccine Sales, 2018-2023
5.3.2 By Application – Global Dendritic Cell Vaccine Sales, 2024-2029
5.3.3 By Application – Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Dendritic Cell Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dendritic Cell Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Dendritic Cell Vaccine Revenue & Forecasts
6.2.1 By Region – Global Dendritic Cell Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Dendritic Cell Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Dendritic Cell Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Dendritic Cell Vaccine Sales & Forecasts
6.3.1 By Region – Global Dendritic Cell Vaccine Sales, 2018-2023
6.3.2 By Region – Global Dendritic Cell Vaccine Sales, 2024-2029
6.3.3 By Region – Global Dendritic Cell Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dendritic Cell Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Dendritic Cell Vaccine Sales, 2018-2029
6.4.3 US Dendritic Cell Vaccine Market Size, 2018-2029
6.4.4 Canada Dendritic Cell Vaccine Market Size, 2018-2029
6.4.5 Mexico Dendritic Cell Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dendritic Cell Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Dendritic Cell Vaccine Sales, 2018-2029
6.5.3 Germany Dendritic Cell Vaccine Market Size, 2018-2029
6.5.4 France Dendritic Cell Vaccine Market Size, 2018-2029
6.5.5 U.K. Dendritic Cell Vaccine Market Size, 2018-2029
6.5.6 Italy Dendritic Cell Vaccine Market Size, 2018-2029
6.5.7 Russia Dendritic Cell Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Dendritic Cell Vaccine Market Size, 2018-2029
6.5.9 Benelux Dendritic Cell Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dendritic Cell Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Dendritic Cell Vaccine Sales, 2018-2029
6.6.3 China Dendritic Cell Vaccine Market Size, 2018-2029
6.6.4 Japan Dendritic Cell Vaccine Market Size, 2018-2029
6.6.5 South Korea Dendritic Cell Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Dendritic Cell Vaccine Market Size, 2018-2029
6.6.7 India Dendritic Cell Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dendritic Cell Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Dendritic Cell Vaccine Sales, 2018-2029
6.7.3 Brazil Dendritic Cell Vaccine Market Size, 2018-2029
6.7.4 Argentina Dendritic Cell Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dendritic Cell Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dendritic Cell Vaccine Sales, 2018-2029
6.8.3 Turkey Dendritic Cell Vaccine Market Size, 2018-2029
6.8.4 Israel Dendritic Cell Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Dendritic Cell Vaccine Market Size, 2018-2029
6.8.6 UAE Dendritic Cell Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Company Summary
7.1.2 3M Business Overview
7.1.3 3M Dendritic Cell Vaccine Major Product Offerings
7.1.4 3M Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 3M Key News & Latest Developments
7.2 Activarti
7.2.1 Activarti Company Summary
7.2.2 Activarti Business Overview
7.2.3 Activarti Dendritic Cell Vaccine Major Product Offerings
7.2.4 Activarti Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Activarti Key News & Latest Developments
7.3 Argos Therapeutics
7.3.1 Argos Therapeutics Company Summary
7.3.2 Argos Therapeutics Business Overview
7.3.3 Argos Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.3.4 Argos Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Argos Therapeutics Key News & Latest Developments
7.4 Batavia Bioservices
7.4.1 Batavia Bioservices Company Summary
7.4.2 Batavia Bioservices Business Overview
7.4.3 Batavia Bioservices Dendritic Cell Vaccine Major Product Offerings
7.4.4 Batavia Bioservices Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Batavia Bioservices Key News & Latest Developments
7.5 Bellicum Pharmaceuticals
7.5.1 Bellicum Pharmaceuticals Company Summary
7.5.2 Bellicum Pharmaceuticals Business Overview
7.5.3 Bellicum Pharmaceuticals Dendritic Cell Vaccine Major Product Offerings
7.5.4 Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Bellicum Pharmaceuticals Key News & Latest Developments
7.6 Creagene
7.6.1 Creagene Company Summary
7.6.2 Creagene Business Overview
7.6.3 Creagene Dendritic Cell Vaccine Major Product Offerings
7.6.4 Creagene Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Creagene Key News & Latest Developments
7.7 DanDrit Biotech
7.7.1 DanDrit Biotech Company Summary
7.7.2 DanDrit Biotech Business Overview
7.7.3 DanDrit Biotech Dendritic Cell Vaccine Major Product Offerings
7.7.4 DanDrit Biotech Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 DanDrit Biotech Key News & Latest Developments
7.8 DCPrime
7.8.1 DCPrime Company Summary
7.8.2 DCPrime Business Overview
7.8.3 DCPrime Dendritic Cell Vaccine Major Product Offerings
7.8.4 DCPrime Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 DCPrime Key News & Latest Developments
7.9 Sanpower Corporation (Dendreon Corporation)
7.9.1 Sanpower Corporation (Dendreon Corporation) Company Summary
7.9.2 Sanpower Corporation (Dendreon Corporation) Business Overview
7.9.3 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Major Product Offerings
7.9.4 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Sanpower Corporation (Dendreon Corporation) Key News & Latest Developments
7.10 Elios Therapeutics
7.10.1 Elios Therapeutics Company Summary
7.10.2 Elios Therapeutics Business Overview
7.10.3 Elios Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.10.4 Elios Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Elios Therapeutics Key News & Latest Developments
7.11 ImmunoCellular Therapeutics
7.11.1 ImmunoCellular Therapeutics Company Summary
7.11.2 ImmunoCellular Therapeutics Dendritic Cell Vaccine Business Overview
7.11.3 ImmunoCellular Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.11.4 ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 ImmunoCellular Therapeutics Key News & Latest Developments
7.12 Immunicum
7.12.1 Immunicum Company Summary
7.12.2 Immunicum Dendritic Cell Vaccine Business Overview
7.12.3 Immunicum Dendritic Cell Vaccine Major Product Offerings
7.12.4 Immunicum Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Immunicum Key News & Latest Developments
7.13 Kiromic
7.13.1 Kiromic Company Summary
7.13.2 Kiromic Dendritic Cell Vaccine Business Overview
7.13.3 Kiromic Dendritic Cell Vaccine Major Product Offerings
7.13.4 Kiromic Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Kiromic Key News & Latest Developments
7.14 Medigene
7.14.1 Medigene Company Summary
7.14.2 Medigene Business Overview
7.14.3 Medigene Dendritic Cell Vaccine Major Product Offerings
7.14.4 Medigene Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Medigene Key News & Latest Developments
7.15 Merck & Co.
7.15.1 Merck & Co. Company Summary
7.15.2 Merck & Co. Business Overview
7.15.3 Merck & Co. Dendritic Cell Vaccine Major Product Offerings
7.15.4 Merck & Co. Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Merck & Co. Key News & Latest Developments
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Company Summary
7.16.2 Northwest Biotherapeutics Business Overview
7.16.3 Northwest Biotherapeutics Dendritic Cell Vaccine Major Product Offerings
7.16.4 Northwest Biotherapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Northwest Biotherapeutics Key News & Latest Developments
7.17 Glaxo Smith Kline
7.17.1 Glaxo Smith Kline Company Summary
7.17.2 Glaxo Smith Kline Business Overview
7.17.3 Glaxo Smith Kline Dendritic Cell Vaccine Major Product Offerings
7.17.4 Glaxo Smith Kline Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Glaxo Smith Kline Key News & Latest Developments
7.18 Tella Incorporation
7.18.1 Tella Incorporation Company Summary
7.18.2 Tella Incorporation Business Overview
7.18.3 Tella Incorporation Dendritic Cell Vaccine Major Product Offerings
7.18.4 Tella Incorporation Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Tella Incorporation Key News & Latest Developments
7.19 Vaxil BioTherapeutics
7.19.1 Vaxil BioTherapeutics Company Summary
7.19.2 Vaxil BioTherapeutics Business Overview
7.19.3 Vaxil BioTherapeutics Dendritic Cell Vaccine Major Product Offerings
7.19.4 Vaxil BioTherapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 Vaxil BioTherapeutics Key News & Latest Developments
8 Global Dendritic Cell Vaccine Production Capacity, Analysis
8.1 Global Dendritic Cell Vaccine Production Capacity, 2018-2029
8.2 Dendritic Cell Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dendritic Cell Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dendritic Cell Vaccine Supply Chain Analysis
10.1 Dendritic Cell Vaccine Industry Value Chain
10.2 Dendritic Cell Vaccine Upstream Market
10.3 Dendritic Cell Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dendritic Cell Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 不活化ポリオウイルスワクチンのグローバル市場展望 2023年-2029年：ヒト二倍体細胞、サル腎臓細胞
  • 卵不使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：細胞培養インフルエンザワクチン、組換えインフルエンザワクチン
  • インフルエンザワクチンのグローバル市場展望 2023年-2029年：3価インフルエンザワクチン、4価インフルエンザワクチン
  • 小児用インフルエンザワクチンのグローバル市場展望 2023年-2029年：点鼻薬、注射
  • IPVワクチンのグローバル市場展望 2023年-2029年：Mahoney株、MEF1株、Saukett株
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8450 )"樹状細胞ワクチンのグローバル市場展望 2023年-2029年：非標的型、標的型" (英文：Dendritic Cell Vaccine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。